Charles River Laboratories International, Inc. (CRL) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Diagnostics & Research
Charles River Laboratories International, Inc. (CRL) Profile & Business Summary
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Key Information
| Ticker | CRL |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.criver.com |
Market Trend Overview for CRL
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-13 (ET)
As of 2026-07-13, CRL is moving sideways without a clear direction. Over the longer term, the trend remains bullish.
CRL last closed at 229.75. The price is about 0.2 ATR above its recent average price (228.06), and the market is currently in a sideways market without a clear direction. Price at 229.75 is moving between minor support near 218.39 and minor resistance near 234.92. Direction remains unclear. View Support & Resistance from Options
The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.
Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 185.82. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-05-28, reflecting a technical shift toward positive directional alignment.
[2026-07-09] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
There was no clear sign of meaningful positions being carried into the overnight session.
As of 2026-07-02, price has extended significantly above its primary volume area, entering a liquidity-thin zone. While the uptrend remains intact, the risk of chasing strength has increased.
The model sees a bullish edge, with 58.8% upside probability and a still-actionable balance between confirmation and reversal risk.
Up probability is 58.8%, with predictability at 51% and signal agreement at 76%. Reversal risk is 11%. That suggests the directional case is supported by broad confirmation and still retains usable quality.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is trading 4.3% above the recent estimated cost basis of 220.26, which keeps the recent cost structure in a clearly stronger position. Price is in the lower half of the main cost band (228.66 to 233.77), so price support and pullback behavior matter more than immediate upside follow-through. The lower down support area sits around 224.28 to 225.01. Recent positioning looks fairly balanced, with 62% in profit and 38% under water. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the main question is whether pullbacks remain controlled before price falls back into the lower support zone.